sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 776-800 out of 1336.

<< < 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>

Public Release: 20-Jun-2016
Just how gestational diabetes puts babies at lifelong risk for cardiovascular disease, under study
Gestational diabetes can put babies at a lifelong risk for cardiovascular disease, and scientists want to better understand how.
NIH/National Institute of Child Health and Human Development

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 20-Jun-2016
Antimicrobial Agents and Chemotherapy
Stealth nanocapsules kill Chagas parasites in mouse models
Lychnopholide, a substance isolated from a Brazilian plant, and formulated as part of 'nanocapsules' cured more than half of a group of mice that had been infected experimentally with Chagas disease parasites. 'Chagas disease affects millions of people, mainly in poor rural areas of 21 Latin American countries,' said Marta de Lana, Ph.D.

Contact: Aleea Khan
American Society for Microbiology

Public Release: 16-Jun-2016
Journal of Health Care Finance
'Disease outbreak guarantees' -- A proposed mechanism for enhancing public health capacity
What if private companies could obtain some coverage to protect their foreign investments in developing countries against crippling infectious disease outbreaks such as Ebola? The possible path to offering disease outbreak guarantees is an idea being posed by two global health researchers who suggest that a mechanism for establishing such an instrument could be tied to public health investments.

Contact: Karen Teber
Georgetown University Medical Center

Public Release: 16-Jun-2016
PLOS Neglected Tropical Diseases
Cholera vaccine study in Haiti suggests problems with current booster regimen
Cholera outbreaks are on the rise. To prevent and control them, three oral cholera vaccines are currently approved by WHO. A study published in PLOS NTDs examining the immune response to one of them in Haitian adults finds that while the first vaccine round elicits a strong cholera-specific response in the mucosa (the first point of contact with the cholera pathogen), the booster dose after 2 weeks does not appear to stimulate the immune system further.

Contact: Jason B. Harris

Public Release: 16-Jun-2016
PLOS Pathogens
Mosquito saliva increases disease severity following dengue virus infection
Insects transmit diseases when, probing for blood vessels, they inject saliva together with viral, bacterial, or parasitic pathogens into the skin of mammalian hosts. A study in mice published on June 16, 2016 in PLOS Pathogens suggests a critical role of mosquito saliva in the outcome of dengue virus infection.

Contact: Michael Schmid

Public Release: 15-Jun-2016
Personalized medicine will employ computer algorithms
Russian scientists have developed a software program enabling them to quickly compare sets of DNA of microorganisms living in different environments. The researchers have already suggested exactly how the new program could be applied in practice. Using the algorithm to compare the microflora of a healthy person with the microflora of a patient, specialists would be able to detect previously unknown pathogens and their strains, which can aid the development of personalized medicine. The results of the study have been published in Bioinformatics.
The Government of Russian Federation, Russian Scientific Foundation

Contact: Dmitry Malkov
ITMO University

Public Release: 15-Jun-2016
Celgene joins DNDi's 'Drug Discovery Booster'
The biopharmaceutical company Celgene has become the fifth company to join the 'Neglected Tropical Diseases Drug Discovery Booster' consortium, a new initiative to accelerate and cut the cost of early stage drug discovery for two of the world's most neglected diseases, leishmaniasis and Chagas disease.

Contact: Violaine Dallenbach
Drugs for Neglected Diseases Initiative

Public Release: 14-Jun-2016
Journal of the American Heart Association
As Olympics near, study finds low levels of physical activity in Brazil
A large study confirms that physical activity provides Brazilians with significant cardio-metabolic health benefits, but reports that fewer than three in 10 participants are active.
Ministry of Health of Brazil, Brazilian Council of Research, University of São Paolo, American Heart Association, Brown University's Brazil Initiative

Contact: David Orenstein
Brown University

Public Release: 14-Jun-2016
Clinical Infectious Diseases
Antibiotics against severe salmonella infections in Africa increasingly ineffective
Salmonella infections in the bloodstream, caused by Salmonella enterica bacteria, are still the cause of many deaths in southern regions and Southeast Asia. Children between the age of two and five years are particularly affected. Treating these infections could become a growing problem owing to increasing antibiotic resistance. DZIF scientists from the Bernhard Nocht Institute for Tropical Medicine have now confirmed that even the newer generations of antibiotics are becoming less and less effective.

Contact: Jürgen May
German Center for Infection Research

Public Release: 14-Jun-2016
Microbial Genomics
Genome sequencing helps determine end of tuberculosis outbreak
Using genome sequencing, researchers from the University of British Columbia, along with colleagues at the Imperial College in London, now have the ability to determine when a tuberculosis outbreak is over.

Contact: Katherine Came
University of British Columbia

Public Release: 14-Jun-2016
New plant engineering method could help fill demand for crucial malaria drug
A new and inexpensive technique for mass-producing the main ingredient in the most effective treatment for malaria, artemisinin, could help meet global demands for the drug, according to a study to be published in the journal eLife.
European Research Council, Max-Planck-Gesellschaft

Contact: Emily Packer

Public Release: 13-Jun-2016
Topical application of antiretroviral drug combination prevents transmission of (S)HIV
Findings published last week in the journal PLOS ONE confirm that researchers from the Oak Crest Institute of Science have demonstrated for the first time that two powerful antiretroviral drugs can provide complete protection against HIV when delivered topically by a sustained release intravaginal ring (IVR) device. The combination of tenofovir disoproxil fumarate and emtricitabine delivered at independently controlled rates via the pod-IVR was successful at preventing SHIV162p3 infection for over four months.

Contact: Dr. Marc M. Baum
Oak Crest Institute of Science

Public Release: 10-Jun-2016
FDA approves vaccine for cholera
In a milestone years in the making, a vaccine to prevent cholera was approved today by the FDA. The vaccine, Vaxchora, is the only approved vaccine in the US for protection against cholera.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 10-Jun-2016
The Open Nursing Journal
An investigation of nurses' job satisfaction in a private hospital and its correlates
Job satisfaction and its impact on staff performance, absenteeism, retention, and turnovers in health care services has been a topic of global interest over decades.

Contact: Faizan ul Haq
Bentham Science Publishers

Public Release: 8-Jun-2016
npj Microgravity
Switched-on Salmonella: Fluid forces guide disease traits of multidrug-resistant bacteria
In new research appearing in the Nature Publishing Group journal npj Microgravity, Cheryl Nickerson, Ph.D., and her colleagues explore the effects of physiological fluid shear on ST313 -- a particularly dangerous type of Salmonella, which is resistant to multiple antibiotics and currently ravaging regions of sub-Saharan Africa.

Contact: Joseph Caspermeyer
Arizona State University

Public Release: 8-Jun-2016
Antimicrobial Agents and Chemotherapy
Modeling the correct doses for disease-fighting drugs
Publishing earlier this week in the American Society for Microbiology's Antimicrobial Agents and Chemotherapy, Brad Reisfeld, associate professor in Colorado State University's Department of Chemical and Biological Engineering, has described a new computational model for optimizing dosing for the tuberculosis drug Rifapentine.

Contact: Anne Ju Manning
Colorado State University

Public Release: 8-Jun-2016
Journal of Neuroscience
Metabolite of multiple sclerosis drug could be safe, effective therapy for Parkinson's disease
The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson's disease, researchers say.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 7-Jun-2016
Proceedings of the National Academy of Sciences
Pneumococcal vaccine watches bacteria, strikes only when needed
Conventional vaccines indiscriminately destroy bacteria and other disease-causing agents. The approach works, but there is growing concern that it creates opportunity other pathogens to harm the body -- similar to antibiotic resistance resulting in new and more potent pathogens. A new, protein-based pneumococcal vaccine takes a different approach. It allows pneumonia-causing bacteria to colonize in the body and -- like a nightclub bouncer -- swings into action only if the bacteria becomes harmful.
National Institutes of Health, Swedish Medical Research Council, Arthur A. Schomburg Fellowship Program at the University at Buffalo

Contact: Cory Nealon
University at Buffalo

Public Release: 7-Jun-2016
Biology Letters
Sexual transmission of Ebola likely to impact course of outbreaks
Sexual transmission of the Ebola virus could have a major impact on the dynamics of the disease, potentially reigniting an outbreak that has been contained by public health interventions, according to research by University of Georgia ecologists just published in the Royal Society journal Biology Letters. The potential for sexual transmission is high for three to four months after the virus has been cleared from the bloodstream, and possible for an average of seven months.
NIH/National Institute of General Medical Sciences, National Science Foundation

Contact: Stephanie Schupska
University of Georgia

Public Release: 6-Jun-2016
Preventive Medicine
1 hour of driving a day = 2.3kg more weight and 1.5cm wider waist, study reveals
A research study led by Professor Takemi Sugiyama from the Australian Catholic University's Institute of Health and Ageing, show the convenience of car travel has a significant impact on public health.

Contact: Rajiv Maharaj
Australian Catholic University

Public Release: 5-Jun-2016
GHIT Fund welcomes ten new partnerships
The Global Health Innovative Technology Fund today welcomed ten new funding partnerships that include major global pharmaceutical and biotechnology companies -- collaborations that will expand investments into research and development for neglected diseases worldwide, many of which have already begun to show progress in clinical trials.

Contact: Katy Lenard

Public Release: 2-Jun-2016
BMC Infectious Diseases
Low risk of dengue infection predicted for foreign visitors to Rio Olympics
Three months before the opening of the Rio de Janeiro Summer Olympics, a group of researchers at University of São Paulo's Medical School (FM-USP) used a mathematical model to calculate the risk of dengue acquisition by the 400,000-odd foreign visitors expected to attend. This model was used with success during the last FIFA World Cup, in 2014. Once again a very low number of dengue cases among foreign visitors to the Olympics is likely, according the study.
São Paulo Research Foundation

Contact: Samuel Antenor
Fundação de Amparo à Pesquisa do Estado de São Paulo

Public Release: 2-Jun-2016
Lancet Infectious Diseases
New study finds that vaccinating mothers against flu can protect newborns
Each year, influenza causes between 250,000 and half a million deaths around the world. Now a new study has shown that immunizing mothers against flu can decrease by 70 percent the risk of their infants getting flu during the first four months after birth. This is the largest study so far to show that maternal vaccination against flu is feasible and effective in resource-poor environments.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 2-Jun-2016
We've got tapeworms and scabies! And reproducible research
Two new research papers on scabies and tapeworms published in the Open Access journal GigaScience also include a collaboration with protocols.io. This collaboration showcases a new way to share scientific methods that allows scientists to better repeat and build on these complicated studies on difficult-to-study parasites. It also highlights a new means of writing all research papers with citable methods that can be updated over time. Keeping work clear, consistent, and current.

Contact: Scott Edmunds

Public Release: 1-Jun-2016
UAB developing training program on Ebola for first responders in Deep South
UAB has received a grant to develop and implement Ebola and infectious disease training to further protect health care and public safety workers.
NIH/National Institute of Environmental Health Sciences

Contact: Alicia Rohan
University of Alabama at Birmingham

Showing releases 776-800 out of 1336.

<< < 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>